Arkolith/Insider Trading/COYA/Form 4

Garren Hideki

DirectorCoya Therapeutics, Inc. (COYA) · full profile →Form 4 · filed Jan 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Buy(P)2K——2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2023Buy(P)1K——1K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-000223) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML